New capsule tested to stop liver Cancer's return
NCT ID NCT07328828
Summary
This study is testing whether Icaritin soft capsules can help prevent liver cancer from returning after surgery in patients at high risk of recurrence. Twenty patients who have had their liver cancer surgically removed will take the capsules and be monitored with regular scans. Researchers will track how long patients remain cancer-free, their overall survival, quality of life, and any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RFS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
the Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.